Investigating the effects of reduced nicotine cigarettes and e-cigarettes on dual tobacco users
A randomized controlled trial of reduced nicotine cigarettes and e-cigarettes among dual users
This study is looking at how lowering the nicotine in cigarettes might help people who smoke both cigarettes and e-cigarettes switch to using e-cigarettes only, which could be better for their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Vermont & St Agric College NIH-funded |
| Lab location | 1 site (Burlington, United States) |
| Project ID | NIH-11004654 on NIH RePORTER |
What this research studies
This research explores how reducing nicotine levels in cigarettes affects individuals who use both cigarettes and e-cigarettes. It aims to understand whether lowering nicotine content can help these dual users transition to using e-cigarettes exclusively, potentially reducing their overall tobacco-related health risks. Participants will be randomly assigned to different groups to evaluate their smoking behaviors and dependence levels over time. The study will also assess the appeal of e-cigarettes as an alternative to traditional cigarettes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who currently use both cigarettes and e-cigarettes.
Not a fit: Patients who exclusively use either cigarettes or e-cigarettes without dual use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to strategies that help dual tobacco users reduce their smoking and improve their health outcomes.
How similar studies have performed: Previous studies have shown that reducing nicotine in cigarettes can lead to decreased smoking behaviors, but this specific approach with dual users is relatively novel.
Where this research is happening
Burlington, United States
- University of Vermont & St Agric College — Burlington, United States (Active)
Researchers
- Principal investigator: Klemperer, Elias M — University of Vermont & St Agric College
- Study coordinator: Klemperer, Elias M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.